It is essentially a molecular lock that detects the presence of medium-chain fatty acids passing through the gut
This long-term efficacy has led medical organizations to view GLP-1 therapy as a viable chronic treatment option, similar to how we approach blood pressure or cholesterol management
Additionally, they suppress glucagon secretion, a hormone that raises blood glucose levels, and delay gastric emptying, which helps to prevent postprandial glucose spikes
Biopsy-proven NASH : Patients with histologically confirmed NASH, particularly those with significant inflammation or early fibrosis (F1-F2), may be considered for off-label GLP-1 therapy, especially if they have failed lifestyle modification or have contraindications to other therapies like vitamin E or pioglitazone
Treatments include NAD+ for cellular repair, Skin Bright for a glowing complexion, and Skin Bright Double for enhanced brightening results